HB2226 provides prescription drug cost credits in health insurance and imposes penalties.
HB2226 amends the act to include prescription drug cost credits in health insurance, ensuring that payments made by drug manufacturers or other third parties are applied toward the consumer's deductible, copayment, coinsurance, or maximum out-of-pocket costs. The bill also imposes penalties for unfair methods of competition and deceptive acts or practices in the conduct of trade or commerce, providing the Attorney General and District Attorneys with certain powers and duties. The Insurance Department of the Commonwealth is granted concurrent jurisdiction to enforce these provisions.
Included in complete analysis
- Overview
- Core Provisions
- Implementation
- Impact
- Legal Framework
- Critical Issues
See what it does, who it affects, and the critical issues in plain language. Free, 30 seconds.